Wiedower, J. A., Zhang, N., Forbes, S. P., Clemens, K., Weipert, C. M., McNeal, A., Stockl, K. M., Tucker, J., Certa, J. M., Morin, P. (2025). Use of targeted therapy, healthcare costs, and survival with large panel testing, narrow testing, or no molecular testing in patients with metastatic non-small cell lung cancer (mNSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8642